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Defining mast cell (MC) function has been clouded by use of mice with Kit mutations. In this and a previous
issue of Immunity, two studies (Dudeck et al., 2011; Feyerabend et al., 2011) clarify MC function by using two
unique mouse models.Understanding the contributions of mast
cells (MCs) to innate and adaptive
immune responses beyond their well-
known role in IgE-mediated mast cell
reactions has been a key area of investi-
gation in the MC field for the past three
decades. Because the development of
lineage progenitors and mature tissue
MCs in vivo is crucially dependent on
the binding of the growth factor stem
cell factor to its receptor Kit, mouse
strains with alterations in the Kit gene
that are MC deficient have been used for
defining MC functions. Both constitutive
connective tissue MC (CTMC) and T cell-
dependent, induced mucosal mast cells
(MMCs) evolve from Kit-regulated pro-
genitors. KitW/Wv mice have truncated
and point-mutated W and Wv alleles,
respectively, leading to reduced Kit ex-
pression, signal transduction, and severe
MC deficiency. However, the important
roles for Kit in the development of
other cell lineages cause KitW/Wv mice to
also be deficient in erythrocytes, neutro-
phils, certain subpopulations of intraepi-
thelial T cells, germ cells, melanocytes,
and pacemaker cells in the intestine.
KitW-sh/W-sh mice have an inversion up-
stream of the Kit gene that leads to a
selective reduction of Kit expression and
hence MC deficiency, but these mice
bear other abnormalities including splenic
myeloid and megakaryocytic hyperplasia,
again probably related to the altered
expression of Kit on progenitor popula-
tions for these lineages. A logical solution
to these issues has been to transfer im-
mature progenitor MCs, derived in vitro
from bonemarrow cells of WT andmutant
strains, to the MC-deficient strains to
define MC-specific contributions in ex-
perimental models. Unfortunately, en-
graftment of bone marrow per se or
bone marrow-derived MCs (BMMCs)668 Immunity 35, November 23, 2011 ª2011leads to abnormal ‘‘reconstitution’’ of
recipient MC-deficient mice in terms of
MC numbers and tissue-specific distribu-
tion (Du et al., 1996; Cozzi et al., 2011).
Hence, it has not been possible with these
MC-deficient strains to separate unequiv-
ocally the contributions of MCs from the
pleiotropic functions of Kit in other cell
lineages.
In this issue and a previous issue of
Immunity, Feyerabend et al. (2011) and
Dudeck et al. (2011), respectively, report
the generation of two strains of mice defi-
cient in MCs independent of alterations
in Kit, thus permitting direct analyses of
the functions of MC in models previously
assessed in Kit-deficient strains. Feyera-
bend et al. (2011) unexpectedly found
MC deletion in mice made heterozygous
for a homologously recombined modified
carboxypeptidase A3 (Cpa3) gene that
has coding sequence for Cre recombi-
nase inserted upstream of the first exon.
MCs were not detected in Cpa3Cre/+
mice in peritoneal lavage and skin by
histochemistry, by cell surface detection
of FcεRI and Kit, or by measuring mRNA
transcripts for five MC proteases. There
were no alterations in other blood or
spleen leukocyte populations in naive
Cpa3Cre/+mice, except for a partial reduc-
tion in splenic basophils. The latter may
have occurred because mouse basophils
express low amounts of Cpa3 mRNA or
because of a shared lineage progenitor
(Charles et al., 2009; Arinobu et al., 2005).
Using this strain, Feyerabend et al.
(2011) show thatCpa3Cre/+ mice are resis-
tant to passive local and systemic IgE-
mediated anaphylaxis, an unequivocally
MC-dependent characteristic shared
with KitW/Wv and KitW-sh/W-sh mice. In con-
trast with KitW/Wvmice but like KitW-sh/W-sh
mice (Mancardi et al., 2011), Cpa3Cre/+
mice are fully susceptible by clinical,Elsevier Inc.histopathologic, and gene expression
profile criteria to an autoimmune inflam-
matory arthritis induced by injection of
sera from KBxN mice that provides
glucose 6-phosphate isomerase autoanti-
bodies to form immune complexes. The
resistance to this pathology in KitW/Wv
but not in KitW-sh/W-sh mice, as previously
reported for inflammatory arthritis in-
duced by anti-type II collagen mAbs
and LPS (Zhou et al., 2007), most likely
reflects the neutropenia of the KitW/Wv
strain. Experimental autoimmune en-
cephalomyelitis, previously reported to
be diminished inKitW/Wvmice and exacer-
bated in KitW-sh/W-sh mice, showed no
MC dependence in Cpa3Cre/+ mice. The
pivotal studies by Feyerabend et al.
redirect prior thinking about MC involve-
ment in these models for autoimmune
diseases.
Importantly, and unlike KitW/Wv mice,
chronic skin inflammation induced by
phorbol myristate acetate in Cpa3Cre/+
mice did not lead to the appearance of
MC as detected histochemically, sug-
gesting there is a deficiency of lineage
precursors in Cpa3Cre/+ but not KitW/Wv
mice. Indeed, this group had previously
noted that blood-borne progenitors for
the MC lineage in naive prenatal mice ex-
pressed mRNA for Cpa3 (Rodewald et al.,
1992). Hence, infectionwithN. brasiliensis
in Cpa3Cre/+ mice failed to induce histo-
logically detectable MMCs in the lamina
propria and epithelium of the small intes-
tine, as well as no increase in intestinal
mRNA or serum protein for mouse MC
protease 1 (Mcpt1), a marker for expan-
sion of both MMC and CTMC (Xing
et al., 2011). The combined studies reveal
that both innate constitutive CTMC (i.e.,
peritoneum and skin) and adaptive induc-
ible MMC (N. brasiliensis infection) are
deficient in Cpa3Cre/+ mice, suggesting
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Figure 1. Segregation of MC-Dependent and Additional Kit-Dependent Roles in
Pathobiologic Responses
Kit drives development of both the myeloid and lymphoid lineages from stem cells. Mast cell progenitors
(MCps), defined by the indicated expression of cell surfacemarkers, generate constitutive MCs in connec-
tive tissue (CTMCs) that contribute to local and systemic IgE-dependent anaphylaxis and hapten-driven
contact hypersensitivity in the skin. Mast cells induced in mucosal tissues in response to Th2 cell-driven
inflammation (MMCs) serve as effector cells of allergic inflammation and in the intestine contribute to
clearance of helminths. In contrast, Kit-dependent cells other than MCs, including cells derived from
lymphoid, myeloid, and nonhematopoietic lineages, appear to drive autoimmune inflammation typified
by antibody-induced arthritis and experimental autoimmune encephalitis models, as well as basal airway
hyperresponsiveness in naive A/J mice (Cozzi et al., 2011). HSC, hematopoietic stem cell.
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Previewsthat the lineage giving rise to both pheno-
types is largely ablated in the strain of
mice reported in the Feyerabend et al.
study.
The approach taken by Dudeck et al.
(2011) centered on the use of Mcpt5-Cre
transgenic mice, in which the coding
region of the first exon of the Mcpt5
gene was replaced with a Cre-encoding
cDNA and inserted randomly into the
genome. In an initial study, these mice
were crossed with a ROSA26-EYFP
reporter strain for Cre-mediated excision
that revealed cells capable of transcrip-
tion of the Mcpt5 gene in skin and perito-
neal CTMCs but not in other leukocytes,
except a small population of NK cells in
the blood. The Mcpt5-Cre mice were
then bred to a Cre-inducible diptheria
toxin receptor (iDTR) line, allowing for
inducible MC deficiency; Mcpt5-Cre
mice were also bred to an R-DTA line,
which expresses diphtheria toxin A in
Cre+ cells so as to provide constitutive
MC deficiency. The Mcpt5-Cre+iDTR+
mice exposed to a single dose of DT ex-
hibited a >97% reduction in peritoneal
MC, whereas multiple systemic plus
even local exposures were required to
obtain comparable reductions in skin.Other leukocytes at those sites or in the
blood were not affected, although the
status of basophils was not reported. In
the stomach of naive mice, DT induced
depletion of MCs in the squamous but
not glandular regions, possibly reflecting
the respective expression of Mcpt5 in
MC at the two sites, although the number
of MCs in the glandular stomach of naive
mice is very small and probably does not
reflect the inducible population of MMCs
in response to helminth infection. Mcpt5-
Cre+R-DTA+ mice exhibited 98% and
89%–97% reductions in peritoneal and
skin MCs, respectively.
Using these strains, the authors re-
ported that DT-treated Mcpt5-Cre+/
iDTR+ mice have greatly diminished ear
swelling that peaks2 hr after local appli-
cation of a sensitizing dose of the contact
hypersensitivity (CHS)-inducing hapten
dinitrofluorobenzene (DNFB), compared
with WT mice. That this swelling reflected
MC activation was shown by suppression
of the response by the MC stabilizer
cromolyn or the H1 receptor antagonist
pyrilamine. In DT-treated Mcpt5-Cre+/
iDTR+ mice challenged with hapten in
the ear 6 days after sensitization in the
back skin, the depletion of MC led toImmunity 35, Ndecreases in ear swelling, vasodilatation,
vascular permeability, and the number of
skin CD4+ T cells, demonstrating the addi-
tional contribution of MCs to the adaptive
CHS response. In contrast, ear swelling in
response to hapten sensitization alone or
with a challenge in KitW-sh/W-sh mice was
not attenuated. Ear swelling was sup-
pressed by depletion of neutrophils in
KitW-sh/W-sh mice, demonstrating that in
the context of the myelodysplasia in this
strain, another leukocyte can replace
mast cells. Irrespective of prior reports
as to whether and in which direction
MCs influence CHS in the Kit mutant
strains, the studies from Dudeck et al.
using the Mcpt5-Cre+ strains provide
strong evidence for MC dependency at
both the innate sensitization and adaptive
challenge phases of CHS.
The mouse strains newly described in
Immunity will permit a more direct sep-
aration of MC and Kit functions in vivo
(Figure 1), which is critical to clarifying
prior findings of immunomodulatory
functions attributed to MCs in complex
models of innate and adaptive immune
responses assessed in strains with Kit
mutations. Clarity as obtained by Dudeck
et al. (2011) in CHS uncovers unexpected
functions, whereas failure to confirm
prior reports as noted by Feyerabend
et al. (2011) could direct attention to iden-
tification of new functions for other cell
types involved in innate and adaptive
immune responses. TheMcpt5-Cre strain
when crossed with floxed gene-deficient
strains could provide a means to delete
expression of molecules in MCs. An
important aspect of theMcpt5-Cre strains
for future study will be to determine
whether they have a deficiency in
MMCs, which are abundantly induced in
helminthic infections. Because Mcpt5
expression accompanies Cpa3 and
Mcpt4 in cultured BMMCs and tissue
CTMCs, it is reasonable to expect that
Mcpt5-Cre+ strains will show reduced
MCp and their derived MMC. Feyerabend
et al. (2011) indicate that all MC classes
are deleted in Cpa3Cre/+ mice, which
supports a role for an early common
progenitor(s) that transcribes the Cpa3
gene. However, if MMCs induced by T
helper 2 (Th2) cell inflammation are selec-
tively spared in Mcpt5-Cre+iDTR+ and/or
Mcpt5-Cre+R-DTA+ mice, it should be
possible to identify the characteristics
of mast cell progenitors destined forovember 23, 2011 ª2011 Elsevier Inc. 669
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Previewsmucosal sites. Overall, the development
of these unique MC-deficient mouse
strains (Dudeck et al., 2011; Feyerabend
et al., 2011) signals the beginning of a
new era of refined understanding of the
contributions of MC to immune and
inflammatory responses.
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